NEW YORK, NY / ACCESSWIRE / June 10, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of shareholders of Deutsche Bank AG (“Deutsche Bank” or the “Company”) (NYSE: DB) and against certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-03539, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Deutsche Bank securities between April 15, 2013 and April 29, 2016 inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased Deutsche Bank securities during the Class Period, you have until July 11, 2016 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased. Click here to join this action.

[Click here to join this class
action]

Deutsche Bank provides investment, financial, and related products and services worldwide.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Deutsche Bank has serious and systemic failings in its controls against financing terrorism, money laundering, aiding against international sanctions, and committing financial crimes; (2) Deutsche Bank’s internal control over financial reporting and its disclosure controls and procedures were not effective; and (3) as a result, Deutsche Bank’s public statements were materially false and misleading at all relevant times.

On July 22, 2014, The Wall Street Journal published an article entitled “Deutsche Bank Suffers From Litany of Reporting Problems, Regulators Said”, stating that the Federal Reserve Bank of New York found that the Company’s U.S. operations suffered from a litany of serious financial-reporting problems that the Company had known about for years but not fixed.

On this news, shares of Deutsche Bank fell $1.05 per share or approximately 3% from its previous closing price to close at $34.80 per share on July 22, 2014, damaging investors.

Over the next two years, more compliance issues at Deutsche Bank came to light, as media outlets and the Company reported investigations by regulators and an internal probe by Deutsche Bank into possible money laundering by Russian clients, causing Deutsche Bank’s share price to fall and damaging investors. Finally, on May 1, 2016, The Financial Times published an article entitled “FCA warns Deutsche on ‘serious’ financial crime control issues”, stating that the United Kingdom’s Financial Conduct Authority (“FCA”) sent a letter to Deutsche Bank on March 2, 2015, accusing it of having “serious” and “systemic” failings in its controls against financing terrorism, money laundering, aiding against international sanctions, and committing financial crimes. The FCA stated that its investigation uncovered, among other things, incomplete documentations, lack of monitoring, and influencing staff to take actions related to specific clients, which all amounted to a “serious” and “systemic” controls failure. On May 1, 2016, Bloomberg published a similar article entitled “Deutsche Bank Said to Be Faulted by FCA Over Lax Client Vetting”, stating that the FCA faulted the Company for “serious” lapses in efforts to thwart money laundering and criticized the Company’s ability to verify client’s abilities and goals, or ensure that it wasn’t aiding organizations subject to international sanctions.

On this news, shares of Deutsche Bank fell $1.62 per share or approximately 9% over the next two trading days to close at $17.34 per share on May 3, 2016, damaging investors.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 441032

TORONTO, ON and NEW YORK, NY / ACCESSWIRE / June 10, 2016 / Micromem Technologies Inc. (CSE: MRM) (OTCQX: MMTIF) (“Micromem”) (“the Company”) announces the private placement of convertible, unsecured debentures in a principal amount totaling $500,000 USD (the “Convertible Debentures”). The Convertible Debentures were issued in exchange for the forgiveness of existing debentures, and bear an interest rate of two percent (2%) per month, calculated daily, and maturing on September 2, 2016. At any time prior to repayment, the outstanding principal and interest of each of the Convertible Debentures may be converted, at the option of the lender, into common shares of the Company at a price per common share of $0.33 US.

About Micromem and MASTInc

MASTInc is a wholly owned U.S.-based subsidiary of Micromem Technologies Inc., a publicly traded (OTCQX: MMTIF) (CSE: MRM) company. MASTInc analyzes specific industry sectors to create intelligent game-changing applications that address unmet market needs. By leveraging its expertise and experience with sophisticated magnetic sensor applications, MASTInc successfully powers the development and implementation of innovative solutions for oil & gas, utilities, automotive, healthcare, government, information technology, manufacturing, and other industries. Visit www.micromeminc.com; www.mastinc.com.

Safe Harbor Statement

This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company’s actual results to differ materially from those projected in such forward-looking statements. In particular, factors that could cause actual results to differ materially from those in forward looking statements include: our inability to obtain additional financing on acceptable terms; risk that our products and services will not gain widespread market acceptance; continued consumer adoption of digital technology; inability to compete with others who provide comparable products; the failure of our technology; the infringement of our technology with proprietary rights of third parties; inability to respond to consumer and technological demands; inability to replace significant customers; seasonal nature of our business; and other risks detailed in our filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements. When used in this document, the words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential,” and similar expressions may be used to identify forward-looking statements.

The CSE or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release that has been prepared by management.

Listing: NASD OTC-QX – Symbol: MMTIF
CSE – Symbol: MRM

Shares issued: 199,243,036
SEC File No: 0-26005
Investor Contact: info@micromeminc.com; Tel. 416-364-2023
Subscribe to receive News Releases by Email on our website’s home page. www.micromeminc.com

SOURCE: Micromem Technologies Inc.

ReleaseID: 441036

NEW YORK, NY / ACCESSWIRE / June 10, 2016 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of Horsehead Holding Corp. (“Horsehead” or the “Company”) (NASDAQ: ZINC) shareholders against certain officers of Horsehead. The class action, filed in United States District Court, District of Delaware, and docketed under 16-cv-00369, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Horsehead securities between May 21, 2014 and February 2, 2016 inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

If you are a shareholder who purchased or otherwise acquired Horsehead securities during the Class Period, you have until June 21, 2016 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

[Click here to join this class action]

Horsehead, together with its subsidiaries, is a leading U.S. producer of zinc metal and a leading recycler of electric arc furnace (“EAF”) dust. The Company derives the majority of its revenues from the sale of zinc.

The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: defendants provided operational updates that misstated the extent and seriousness of the Mooresboro Facility’s problems, provided zinc production figures detached from the widespread and unsolved defects throughout the production process, and failed to disclose cash and revenue shortfalls that threatened the Company’s ability to pay its creditors and complete the facility’s ramp-up.

On January 23, 2015, Horsehead conducted a secondary offering of 5.75 million shares of its common stock at $12.75 per share (the “Secondary Offering”). As a result of the Secondary Offering, the Company generated approximately $73 million in gross offering proceeds. The registration statement (“Registration Statement”), which incorporated a prospectus supplement (“Prospectus”), issued in connection with the Secondary Offering contained false and misleading statements of fact and failed to disclose facts required to be disclosed therein under the rules and regulations regarding its preparation.

Then, in a series of partial disclosures, Horsehead revealed in piecemeal fashion various production problems at the Mooresboro Facility. Although defendants disclosed certain production issues at the Mooresboro Facility, they falsely assured investors that the problems were minor in nature, fixable and would not threaten the viability of the facility, the new production processes being used, or the Company’s long-term business and prospects.

Approximately one month later, on December 10, 2015, ratings agency Moody’s downgraded the Company’s corporate debt from B3 to Caa2 on a negative outlook due to recurring problems at the Mooresboro Facility. By early January 2016, the Company had failed to make a $1.8 million interest payment to certain holders of the Company’s convertible senior notes and shortly thereafter defaulted on multiple credit agreements.

On January 22, 2016, Horsehead announced that it was idling the Mooresboro Facility and laying off most employees at the site.

On February 2, 2016, Horsehead announced that it had initiated bankruptcy proceedings under Chapter 11 of the U.S. Bankruptcy Code. That same day, the Company filed a plan for restructuring based on its discussions with secured creditors that revealed “‘[m]ajor [b]ottlenecks” at the Mooresboro Facility. The filing stated that “[s]ignificant issues” plagued several steps in the zinc production and recycling process, including: (i) solid/liquid separation; (ii) depletion; (iii) bleed treatment; and (iv) cementation. The filing also stated that gypsum precipitation and lead/silver recovery at the plant suffered from “equipment sizing issues,” and that all steps of the production process had at least “[l]imited issues.” In addition, the filing stated that it would take approximately $81.9
million and over two years to get the facility back on track.

On February 11, 2016, trading in Horsehead stock was suspended. On February 23, 2016, Horsehead filed a notice on Form 25-NSE that its common stock had been removed from listing on the NASDAQ stock exchange.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 441031

Developing the Oral Immunotherapy AR101 for Desensitization of Peanut Allergies; Report Available here: http://www.lifescicapital.com/equity-research/aimmune/

NEW YORK, NY / ACCESSWIRE / June 10, 2016 / LifeSci Capital, LLC, a research-driven investment bank with deep domain expertise in the life sciences sector, today announced that it has initiated coverage of Aimmune Therapeutics (NasdaqGS: AIMT), a biopharmaceutical company developing allergy desensitization treatments for patients with peanut and other food allergies. No therapies are available to address the growing prevalence of severe peanut allergies, leaving these patients at risk of life-threatening anaphylaxis upon accidental exposure to peanuts. Aimmune’s lead product candidate is AR101, a proprietary peanut formulation based on the Company’s characterized oral desensitization immunotherapy (CODIT) platform.

The alarming rise in peanut and other food allergies is undisputed. In the past 13 years allergists have witnessed the peanut allergy rate more than quadruple. More than 5 million children and adults are estimated to have peanut allergies. Currently, there is no approved treatment for those with peanut allergies, and the looming risk of deadly reactions to an often hidden food product has spurred a demand for potentially life-saving desensitization therapies.

Aimmune’s Phase II data demonstrate that patients who underwent AR101 immunotherapy were able to withstand peanut exposure at amounts in excess of a typical event of accidental dietary exposure. This success positions Aimmune to be the first in class offering an efficacious peanut desensitization therapy that may protect peanut allergic individuals from life threatening anaphylactic episodes. Our estimates indicate that even modest penetration of the peanut allergy market could lead to sales for AR101 of more than $1 billion per year.

In a 38 page Initiation Report LifeSci Capital explains the scientific rationale behind Aimmune’s clinical program, provides estimates for the peanut allergy market, and discusses the clinical data generated to date, as well as that of competitors.

Dr. Isaacson’s full Initiation Report, including important disclosures, is available to download at no cost at the LifeSci Capital website, www.lifescicapital.com/equity-research/. In addition to this Initiation Report, LifeSci Capital intends to provide ongoing coverage and event-based research updates on Aimmune as developments occur.

The LifeSci Capital research team is led by Dr. Jerry Isaacson, an industry veteran with broad experience in biotechnology, having worked in both public and private biotech companies in areas ranging from medicinal chemistry and analytical chemistry to patents and investor/public relations. Dr. Isaacson holds a Bachelor of Arts degree in Chemistry from Harvard University and received his Ph.D. in Organic Chemistry from the University of California in San Diego.

About LifeSci Capital:

LifeSci Capital (Member: FINRA/SIPC) is a research-driven investment bank with deep domain expertise in the life sciences. Our service model as a boutique investment bank is unique in that we exclusively serve emerging life science companies that discover, develop, and commercialize innovative products. We view our clients as our partners, and we work closely with them to establish and execute their capital markets strategies. Our broadly-distributed equity research product is differentiated and provides a deep understanding of our clients’ businesses and the opportunities they are addressing. To learn more about LifeSci Capital, visit the company’s website, www.lifescicapital.com.

Analyst Contact:

Jerry Isaacson, Ph.D.
Phone: (646) 597-6991
Email: jisaacson@lifescicapital.com

SOURCE: LifeSci Capital, LLC

ReleaseID: 441027

VANCOUVER, BC / ACCESSWIRE / June 10, 2016 / Viscount Systems, Inc. (OTCQB:VSYS) (“Viscount”), a software company specializing in physical and logical security solutions, today announced its first quarter financial results for the period ending March 31, 2016.

“Viscount is focused on aligning operations to improve execution across the business,” said Scott Sieracki, CEO, Viscount Systems. “Our decision to sell the service division will help us realize further cost reduction and efficiencies. In the first quarter, customer demand for the Freedom unified access control solution remained high and our sales team has worked diligently to drive opportunity in our target markets to support sustained growth.”

First Quarter 2016 Highlights

Sales for the three months ended March 31, 2016 and 2015 were $981,878 and $1,054,480, respectively, reflecting a decrease of $72,602 or 7%. Freedom sales for the three months ended March 31, 2016 and 2015 were $329,707 and $441,105, respectively, reflecting a decrease of $111,398 or 25%, which was mostly due to lower Freedom equipment sales during the three months ended March 31, 2016. The decrease in Freedom sales were partially offset by an increase of $38,796 or 6% from Mesh/Enterphone sales for the three months ended March 31, 2016, compared to 2015. Mesh/Enterphone sales for the three months ended March 31, 2016 and 2015 were, $652,171 and $613,375, respectively.

Gross Profit

Gross profit for the three months ended March 31, 2016 and 2015 was $530,079 and $490,817, respectively, an increase of $39,262 or 8%. For the three months ended March 31, 2016 and 2015, cost of sales were $451,799 and $563,663 or, as a percentage of sales, was 46% and 53%, respectively. Included in cost of sales is a recovery of inventory obsolescence and shrinkage amounting to $51,278 and $0 for the three months ended March 31, 2016 and 2015, respectively.

Gross margin for the three months ended March 31, 2016 and 2015 was 54% and 47%, respectively. During the three months ended March 31, 2016, management has continued to focus on controlling costs by using multiple suppliers to ensure that the best and most cost effective raw materials are used in all of our products.

The gross margin percentage for three months ended March 31, 2016 of our product categories of Mesh/Enterphone and Freedom, were 47% and 67%, respectively. The gross margin percentage for the three months ended March 31, 2015 of product categories of MESH/Enterphone and Freedom were 28% and 73%, respectively.

Income from Discontinued Operations

Discontinued operations represent the company’s servicing business as a result of the its decision to sell this line of business.

Income from discontinued operations is attributable to the net income related to the Service Division as a result of our decision in January 2016 to sell the Service Division. Income from discontinued operations of $82,993 for the three months ended March 31, 2016 is comprised of sales revenues of $222,965, cost of sales of $89,061 and operating expenses of $50,911. Income from discontinued operations of $96,728 for the three months ended March 31, 2015 is comprised of sales revenues of $270,416, cost of sales of $96,715 and operating expenses of $76,973.

Replay

A replay of the financial results conference call is available on the Viscount Web Site.

About Viscount

Viscount is the leading provider of next-generation, IT-centric access control and identity management applications. Viscount’s Freedom application platform allows seamless unification of the physical and digital security worlds by replacing discrete, self-contained systems with an integrated security system that is sophisticated enough to protect today’s critical business assets, and flexible enough to keep up with the evolving IT infrastructures of government and private organizations. For more information please visit: www.viscount.com

Safe Harbor Statement

Forward looking statements: This press release and other statements by Viscount Systems, Inc. may contain forward-looking statements with respect to the outlook for earnings and revenues, other future financial or business performance, strategies and expectations. Forward-looking statements are typically identified by words or phrases such as “believe,” “expect,” “estimate,” “position,” “assume,” “potential,” “outlook,” “continue,” “remain,” “maintain,” and similar expressions, or future or conditional verbs such as “will,” “would,” “should,” “could,” or similar expressions.

Media Contact:

Rhianna Daniels Hile
603-591-7209
Rhianna@compassintegrated.com

SOURCE: Viscount Systems, Inc.

ReleaseID: 441028

HALIFAX, NS / ACCESSWIRE / June 10, 2016 / Troy Grant, President and CEO of ELCORA ADVANCED MATERIALS CORP. (TSXV: ERA) (OTCQB: ECORF) (FSE: ELM), (the “Company” or “Elcora”), is pleased to announce that the Company has closed the first tranche of the non-brokered private placement financing (the “Private Placement”) announced on April 26, 2016. The Private Placement is up to 7,500,000 units (“Units”) at a price of $0.40 per Unit to raise aggregate gross proceeds of up to $3,000,000. Each Unit will be comprised of one common share and half common share purchase warrant. Each full warrant gives the holder the right to purchase one additional common share of Elcora at an exercise price of $0.52 for three years following the closing of the Private Placement.

Elcora has issued 2,208,750 Units at a price of $0.40 per Unit for aggregate gross proceeds of $883,500. The Company issued 2,208,750 share purchase warrants entitling the holder to purchase one additional common share of Elcora at an exercise price of $0.52 for three years following the closing of the Private Placement. The Company will pay finders’ fees of $13,100 in cash and 15,000 in finders’ warrants in connection with this tranche of the Private Placement.

All securities issued pursuant to the Private Placement will be subject to a statutory four-month hold period. The proceeds from the Private Placement will be used for funding additional Lithium-Ion battery testing and for general corporate purposes.

About Elcora Advanced Materials

Elcora was founded in 2011 and has been structured to become a vertically integrated graphite & graphene company that mines, processes, refines graphite, and produces both the graphene and end user graphene applications.  As part of the vertical integration strategy, Elcora has secured high-grade graphite and graphene precursor graphite from its interest in the operation of the Ragedara mine in Sri Lanka which is already in production. Elcora has developed a unique low cost effective processes to make high quality graphite and graphene that are commercially scalable. This combination means that Elcora has the tools and resources for graphite and graphene vertical integration.

For further information please visit the company’s website at http://www.elcoracorp.com.

For further information please contact: Troy Grant, Director, President and CEO, Elcora Resources Corp., T: 902 802-8847 F: 902 446-2001.

CAUTIONARY STATEMENT:

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release. No stock Exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. This News Release includes certain “forward-looking statements”. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding potential mineralization and reserves, exploration results, and future plans and objectives of Elcora, are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Elcora’s expectations are exploration risks detailed herein and from time to time in the filings made by Elcora with securities regulators.

Investors are cautioned that, except as disclosed in the filing statement prepared in connection with the transaction, any information released or received with respect to the transaction may not be accurate or complete and should not be relied upon.

SOURCE: Elcora Advanced Materials

ReleaseID: 441025

POMPANO BEACH, FL / ACCESSWIRE / June 10, 2016 / DS Healthcare Group, Inc. (DSKX) (the “Company”) received a letter from Nasdaq dated June 7th, 2016 indicating that Nasdaq had not received the Company’s Form 10-Q for the quarter ended March 31, 2016, in addition to remaining delinquent in filing its Form 10-K for the period ended December 31, 2015 (the “Initial Delinquent Filing”). As a result, Nasdaq indicated that the Company does not comply with the Nasdaq Listing Rules (the “Rules”) for continued listing.

The Company’s plan of compliance with respect to its Initial Delinquent Filing was submitted to Nasdaq on May 11, 2016. Nasdaq made an additional information request dated May 27, 2016 (“May 27 Letter”), wherein Nasdaq staff requested, among other items, that the Company provide a detailed description of the steps required to be completed before the Company can become current in its periodic reporting obligations. In the Company’s response to the May 27 Letter, the Company will incorporate any pertinent updates to the Company’s original plan to regain compliance with respect to the filing requirement. Any exception to allow the Company to regain compliance, if granted, will be limited to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or October 11, 2016.

DS Healthcare’s auditor Malone Bailey is currently working to complete the audit for all delinquent filings as soon as possible.

About DS Healthcare Group

DS Healthcare Group Inc. develops novel biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and physicians. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Healthcare Group or its flagship brands, visit www.dshealthgroup.com.

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies, and are generally preceded by words such as “future,” “plan” or “planned,” “expects,” or “projected.” These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company’s control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing, current litigation against the Company, ongoing regulatory investigations of the Company, Nasdaq’s trading halt of the Company’s common stock and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at www.sec.gov.

Investor Relations

DS Healthcare Group
(888) 404-7770 ext. 3
investors@dshealthgroup.com

SOURCE: DS Healthcare Group Inc.

ReleaseID: 441021

EDMONTON, AB / ACCESSWIRE / June 10, 2016 / Altiplano Minerals Ltd. (TSXV: APN) (“APN” or the “Company“) announces that it has completed the previously announced non-brokered private placement (the “Offering“) of 6.0 million units (the “Units“) at C$0.10 per Unit to raise C$600,000 in gross proceeds. Each Unit consisted of one (1) common share and one-half (½) of a non-transferable share purchase warrant (the “Warrants“) of the Company. Each whole Warrant is exercisable to acquire one (1) additional common share at $0.15 per share until June 6, 2017.

All of the securities issued pursuant to this Offering will have a hold period expiring on October 7, 2016. The net proceeds of the Offering will be used primarily for the Company’s general working capital purposes.

About Altiplano

Altiplano Minerals Ltd. (TSXV: APN) is a mineral exploration company focused on evaluating and acquiring projects with significant potential for advancement from discovery through to production, in Canada and abroad. Management has a substantial record of success in capitalizing opportunity, overcoming challenges and building shareholder value. Additional information concerning Altiplano can be found on its website at www.altiplanominerals.com.

ON BEHALF OF THE BOARD

/s/ “John Williamson”
President and CEO
Tel: (780) 437-6624

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the (TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This release includes certain statements that may be deemed “forward-looking statements”. All statements in this release, other than statements of historical facts, that address exploration drilling, exploitation activities and events or developments that the Company expects are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continuity of mineralization, uncertainties related to the ability to obtain necessary permits, licenses and title and delays due to third party opposition, changes in government policies regarding mining and natural resource exploration and exploitation, and continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. For more information on the Company, investors should review the Company’s continuous disclosure filings that are available at www.sedar.com.

SOURCE: Altiplano Minerals Ltd.

ReleaseID: 441022

VANCOUVER, BC / ACCESSWIRE / June 10, 2016 / American CuMo Mining Corporation (TSXV: MLY) (OTC: MLYCF) (“CuMoCo” or the “Company”) is pleased to announce that its non-brokered private placement of up to 10,000,000 units (“CuMoCo Units”) at a price of Cdn$0.10 per unit for gross proceeds of up to $1,000,000 (the “CuMoCo Offering”), announced on May 12, 2016 has been closed and oversubscribed. The Board of Directors approved an increase to the size of the CuMoCo Offering, and the Company has sold a total of 10,241,500 CuMoCo Units for total gross proceeds of $1,024,150. A portion of the proceeds of the CuMoCo Offering will be applied to reduce the Company’s working capital deficit and the remainder for general corporate purposes.

Each CuMoCo Unit consists of one common share of the Company and one share purchase warrant (a “Warrant”) exercisable to purchase one common share of the Company at a price of Cdn $0.15 per common share until June 9, 2021 subject to an acceleration provision whereby the term of the Warrants may be accelerated in the event that the Company’s common shares trade at or above a price of Cdn $0.20 per share for a period of 10 consecutive trading days. In such case, the Company may, at its option, accelerate the expiry date by delivery of notice to the holder and issuing a press release announcing such acceleration, and, in such case, the expiry date of the Warrants shall be deemed to be the 20th day following the later of the date on which the acceleration notice is sent to the holder of the Warrants and the date of issuance of the press release. All securities issued pursuant to the CuMoCo Offering will be subject to a four month hold period, expiring on October 10, 2016.

Insiders and their associated parties, each being a “related party” of the Company (as such term is defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”)), have subscribed for a total 600,000 CuMoCo Units, as follows: Shaun Dykes (President, CEO and a director of the Company) and his associated parties, for 500,000 CuMoCo Units; and Trevor Burns (Vice-President, Corporate Communications, CFO and a director of the Company) for 100,000 CuMoCo Units. The Company has relied upon the exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 contained in Sections 5.5(a) and 5.7(1)(a) of MI 61-101 based on the fact that the fair market value of the related party participation in the CuMoCo Offering will not exceed 25% of the Company’s market capitalization prior to the closing of the CuMoCo Offering. The Board of Directors approved the participation of insiders in the CuMoCo Offering with the individual insiders who are directors abstaining from voting on their participation.

The Company also announces that it has granted options to purchase up to 2,400,000 common shares of the Company to directors and consultants at a price of $0.15 per share exercisable for a period of five years.

In other news, the Company has commenced its summer work on the CuMo Project, conducting various required surveys as part of the permitting process and is actively working with its new financing partners (see June 6, 2016 Press Release) to secure US$ 25 million as the first major step towards a definitive agreement.

About CuMoCo

CuMoCo is focused on advancing its CuMo Project towards feasibility and establishing itself as one of the largest and lowest-cost molybdenum producers in the world as well as a significant producer of copper and silver. Management is continuing to build an even stronger foundation from which to move the Company and the CuMo Project forward. For more information, please visit www.cumoco.com and www.cumoproject.com.

For further information, please contact:

American CuMo Mining Corporation

Shaun Dykes, President and Chief Executive Officer

Tel: (604) 689-7902
Email: info@cumoco.com

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this new release.

Forward-looking information

This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation including, but not limited to, statements that address activities, events or developments that the Company expects or anticipates will or may occur in the future, such as the Company’s ability to successfully negotiate the Definitive Agreement with the Chinese Partners, the Company’s ability to move the CuMo Project through development to feasibility and production, and for the Company to become one of the largest and lowest-cost molybdenum producers in the world as well as a significant producer of copper and silver. Forward-looking information is based on a number of material factors and assumptions, including the result of exploration activities, the ability of the Company to raise the financing for a feasibility study and to put the CuMo project into production, that no labour shortages or delays are experienced, that plant and equipment function as specified, that the Court will not intervene with the Company’s proposed exploration activities at the CuMo Project, and the ability of the Company to obtain all requisite permits and licenses to advance the CuMo Project and eventually bring it into production. Forward-looking information involves known and unknown risks, future events, conditions, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future prediction, projection or forecast expressed or implied by the forward-looking information. Such factors include, among others, the interpretation and actual results of current exploration activities; changes in project parameters as plans continue to be refined; future prices of molybdenum, silver and copper; possible variations in grade or recovery rates; labour disputes and other risks of the mining industry; delays in obtaining governmental approvals or financing, as well as those factors disclosed in the Company’s publicly filed documents, including the Company’s Management’s Discussion and Analysis for the period ended March 31, 2016. There may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.

SOURCE: American CuMo Mining Corporation 

ReleaseID: 441017

ARVADA, CO / ACCESSWIRE / June 10, 2016 / Digital Info Security Company (OTC: DGIF), announced that it will effect a 1-for-40 reverse stock split of its outstanding common stock effective June 15th, 2016 (“Effective Time”). As a result of the reverse stock split, every forty shares of the Company’s common stock issued and outstanding as of the Effective Time will be consolidated into one issued and outstanding share. Should the reverse stock split result in any of the Company’s stockholders owning a fractional share, such fractional share will be rounded up to the next highest whole share.

The Company has retained its transfer agent, Mountain Share Transfer, LLC. (“MST”) www.mountainsharetransfer.com, to act as its exchange agent for the reverse stock split. MST will provide stockholders of record as of the Effective Time with a letter of transmittal providing instructions for the exchange of their stock certificates. Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to brokers’ particular processes, and will not be required to take any action in connection with the reverse stock split. From the effective time there will be a temporary stock symbol change for 20 days adding a D to the symbol (DGIFD). A reverse stock split within a range of one-for-forty was approved by the Company’s majority stockholders at a meeting of Stockholders held on November 30th, 2015 and the specific ratio of one-for-forty was subsequently approved by the Company’s Board of Directors. This action has been taken in order to facilitate future business transactions and acquisitions to be announced at a later date.

FURTHER INFORMATION

For additional information about the content found in this release or about Digital Info Security Company, contact James R Clark at 720-427-8938

SAFE HARBOR STATEMENT

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect,” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently, and other factors detailed in reports filed by the Company.

SOURCE: Digital Info Security Company

ReleaseID: 441018